Anne Wojcicki has outbid Regeneron with a $305 million offer to reclaim 23andMe, the genetic health tech company she co-founded.
Regeneron is acquiring 23andMe’s core assets for $256 million following the genetic testing company’s Chapter 11 filing.
Sign Up to Our Newsletter
